TWOSTONE&Sons Inc. Logo

TWOSTONE&Sons Inc.

An engineer platform providing IT talent and marketing services for corporate digital transformation.

7352 | T

Overview

Corporate Details

ISIN(s):
JP3830720003
LEI:
Country:
Japan
Address:
渋谷区渋谷2−22−3渋谷東口ビル6F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

TWOSTONE&Sons Inc. is a holding company that provides solutions centered on its engineer platform. The company's operations are primarily organized into two segments: Engineer Platform Services and Marketing Platform Services. It specializes in supplying IT engineering resources to corporate clients, supporting their digital transformation (DX) initiatives, and offering digital marketing services. Key offerings include the IT talent platforms Midworks and TechStars, and the programming school tech boost, which nurtures engineering talent. Operating under the vision "BREAK THE RULES," the company aims to solve social challenges by creating new value and challenging conventional business norms through its technology-focused services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-30 09:26
Capital/Financing Update
臨時報告書
Japanese 18.9 KB
2025-04-30 09:25
M&A Activity
臨時報告書
Japanese 33.8 KB
2025-04-14 08:37
Interim Report
半期報告書-第12期(2024/09/01-2025/08/31)
Japanese 246.6 KB
2025-04-14 08:37
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-11-29 07:54
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB
2024-11-28 07:51
Governance Information
内部統制報告書-第11期(2023/09/01-2024/08/31)
Japanese 23.6 KB
2024-11-28 07:50
Registration Form
確認書
Japanese 8.7 KB
2024-11-28 07:49
Annual Report
有価証券報告書-第11期(2023/09/01-2024/08/31)
Japanese 1.5 MB
2024-11-25 08:54
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-10-08 08:01
Regulatory News Service
臨時報告書
Japanese 35.5 KB
2024-07-12 08:34
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-07-12 08:33
Quarterly Report
四半期報告書-第11期第3四半期(2024/03/01-2024/05/31)
Japanese 210.8 KB
2024-05-31 09:52
Share Issue/Capital Change
訂正臨時報告書
Japanese 35.9 KB
2024-05-16 08:56
Share Issue/Capital Change
臨時報告書
Japanese 37.2 KB
2024-04-25 02:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 34.3 KB

Automate Your Workflow. Get a real-time feed of all TWOSTONE&Sons Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TWOSTONE&Sons Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TWOSTONE&Sons Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.